japan beat claim us sale
report oper ep estim
consensu beat result better expect
margin japan mainli driven favor claim experi
like includ favor develop well lower oper
expens modestli favor claim experi us top-line
growth region line expect lower hedg
cost japan off-set continu pressur nii low interest
rate premium growth us came low end prior
guidanc sale us grew y/i bring fy
sale growth high end afl long term guidanc
ahead expect outweigh subdu sector
sale japan final return quarter
slightli higher expect due share repurchas
vs estim view commentari
around capit return recent fab modestli neg
increas quarterli dividend sign confid term
manag view current capit posit also note
gave ep guidanc impact lower tax rate factor
essenti line adjust lower
tax rate view solid quarter better expect
earn larg driven favor claim reserv adjust
sale consolid basi roughli line stronger
us off-set slighter weaker japan follow quarter
rais oper ep estim
respect larg due assum lower tax rate previous
model chang price target
chang earn forecast
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
oper earn japan came estim
posit result larg driven favor morbid claim sector benefit ratio
improv bp sequenti almost bp vs recogn
improv combin benefit ratio partial function mix-shift
sector product sector product carri lower benefit ratio rel sector
product lower incur claim driven declin hospit rate note
recent investor day addit expens came modestli lower anticip
think could indic prior invest platform fund part
invest recent mention though yet complet final
sector sale bit light vs estim rel flat y/i due tough comp
thought cancer sale held fairli well sequenti improv medic
encourag howev still expect japan sale pressur
heavili depend new product launch tough comp rel
manag telegraph sinc fab meet
us report oper earn estim
result driven lower oper expens favor claim experi
expect partial off-set higher polici acquisit cost top-line growth y/i
rel line come low end manag previou guidanc rang
highlight quarter think key area focu call tomorrow
sale growth y/i us like driven mix-shift career broker
channel ad agent broker channel sequenti almost doubl
sinc last year could indic compani make progress overcom
distribut challeng pronounc middl market group busi
product also show solid improv though season measur
given recent neg public around sale practic compani think
posit sale result quarter temper recent fear futur growth potenti
pt impli trade price-to-earnings multipl oper ep estim
risk pt includ rise japanes govern bond yield strong sale result introduct new
disabl incom product improv margin third sector cancer product
reinsur group america inc
articl articl
time dissemin januari et
analyst thoma gallagh kosta kasidako andi primarili respons prepar research report attest
follow view opinion render research report reflect person view subject compani issuer
part research analyst compens directli relat specif recommend view
